Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_assertion type Assertion NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_head.
- NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_assertion description "[The concomitant 1p partial loss and chromosome 19 alterations, with the +7 and -10-specific GBM markers associated with homozygous deletion of 9p21.3 including CDKN2A (p16), are distinct features of the glioblastoma MI-4 cell line, illustrating its origin from an olidodendroglial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_provenance.
- NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_assertion evidence source_evidence_literature NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_provenance.
- NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_assertion SIO_000772 16102584 NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_provenance.
- NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_assertion wasDerivedFrom befree-2016 NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_provenance.
- NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_assertion wasGeneratedBy ECO_0000203 NP508922.RAZ70PUCxCuUBTOB8c4DHA2AAIaXJI4aKPbv5gL96lHsM130_provenance.